Search

everythinglearnresearchcommunity

for

Search:↓

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Androgenetic alopecia negatively impacts quality of life, especially for women, due to social reactions.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

Disease-specific tools better assess alopecia areata's impact on quality of life.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

Diffuse lichen planopilaris greatly reduces quality of life.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Hair disorders significantly reduce quality of life.

Older men with late-onset lupus have a higher mortality rate than women.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Hair loss significantly affects emotional and social well-being.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Fungal skin infections significantly lower patients' quality of life.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Hair loss significantly affects emotional and social well-being.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.